REGENERON PHARMACEUTICALS, INC.·4

Dec 10, 4:03 PM ET

STAHL NEIL 4

4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 10, 2024

Insider Transaction Report

Form 4
Period: 2024-12-09
STAHL NEIL
SVP Res and Dev Sciences
Transactions
  • Tax Payment

    Common Stock

    2024-12-09$787.00/sh466$366,74249,133 total
Holdings
  • Common Stock

    (indirect: By Trust)
    4,605
  • Common Stock

    (indirect: By 401(k))
    5,849

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT